{"created_at":"Sun Apr 27 15:01:25 +0000 2014","id":460433542644658176,"id_str":"460433542644658176","text":"Movers and Shakers: Recently Upgraded: $WFT $GIMO $CRUS $DV $SYNA $BLDR $AWAY $CELG $WFC $BIDU $TXN $ELY $ORLY $TQNT $GT #markets #trading","source":"\u003ca href=\"http:\/\/stocksignaling.com\/twitterapp\/\" rel=\"nofollow\"\u003eStock Signaling\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":954921476,"id_str":"954921476","name":"Stock Signaling","screen_name":"StockSignaling","location":"New York, NY","url":"http:\/\/stocksignaling.com","description":"Stock Signaling Analytics. Market Catalysts, Trends, and Advanced Filtering & Trading Reports. Find top trading stocks moving on late-breaking developments.","protected":false,"followers_count":4180,"friends_count":2371,"listed_count":101,"created_at":"Sun Nov 18 05:53:56 +0000 2012","favourites_count":0,"utc_offset":-14400,"time_zone":"Eastern Time (US & Canada)","geo_enabled":false,"verified":false,"statuses_count":14567,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"1A1B1F","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme9\/bg.gif","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme9\/bg.gif","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2863579819\/4e6a83d8fd94c35b573074cf102a7948_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2863579819\/4e6a83d8fd94c35b573074cf102a7948_normal.jpeg","profile_banner_url":"https:\/\/pbs.twimg.com\/profile_banners\/954921476\/1354488201","profile_link_color":"2FC2EF","profile_sidebar_border_color":"181A1E","profile_sidebar_fill_color":"252429","profile_text_color":"666666","profile_use_background_image":true,"default_profile":false,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[{"text":"markets","indices":[121,129]},{"text":"trading","indices":[130,138]}],"symbols":[{"text":"WFT","indices":[39,43]},{"text":"GIMO","indices":[44,49]},{"text":"CRUS","indices":[50,55]},{"text":"DV","indices":[56,59]},{"text":"SYNA","indices":[60,65]},{"text":"BLDR","indices":[66,71]},{"text":"AWAY","indices":[72,77]},{"text":"CELG","indices":[78,83]},{"text":"WFC","indices":[84,88]},{"text":"BIDU","indices":[89,94]},{"text":"TXN","indices":[95,99]},{"text":"ELY","indices":[100,104]},{"text":"ORLY","indices":[105,110]},{"text":"TQNT","indices":[111,116]},{"text":"GT","indices":[117,120]}],"urls":[],"user_mentions":[]},"favorited":false,"retweeted":false,"filter_level":"medium","lang":"en"}
{"created_at":"Sun Apr 27 16:29:44 +0000 2014","id":460455768244756480,"id_str":"460455768244756480","text":"RT @PDRennert: cell death manipulation again: among the CD47 antibodies, the $CELG Inhibrx drug is advancing http:\/\/t.co\/NqoLt9VDGT (nb. st\u2026","source":"\u003ca href=\"http:\/\/twitter.com\/download\/iphone\" rel=\"nofollow\"\u003eTwitter for iPhone\u003c\/a\u003e","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":305221233,"id_str":"305221233","name":"Dr. Zoidberg","screen_name":"psuvafan007","location":"San Francisco, CA","url":null,"description":"Ph.D. Oncology, Patent Agent, Biotech stock enthusiast, professional dilettante, and fan of market inefficiencies.","protected":false,"followers_count":257,"friends_count":179,"listed_count":10,"created_at":"Wed May 25 21:08:36 +0000 2011","favourites_count":917,"utc_offset":null,"time_zone":null,"geo_enabled":false,"verified":false,"statuses_count":1170,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/378800000386646442\/053beabf5612d07359246d2d7688872f_normal.png","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/378800000386646442\/053beabf5612d07359246d2d7688872f_normal.png","profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweeted_status":{"created_at":"Sun Apr 27 13:12:53 +0000 2014","id":460406228985065472,"id_str":"460406228985065472","text":"cell death manipulation again: among the CD47 antibodies, the $CELG Inhibrx drug is advancing http:\/\/t.co\/NqoLt9VDGT (nb. stock pump)","source":"web","truncated":false,"in_reply_to_status_id":null,"in_reply_to_status_id_str":null,"in_reply_to_user_id":null,"in_reply_to_user_id_str":null,"in_reply_to_screen_name":null,"user":{"id":1001726569,"id_str":"1001726569","name":"Paul D. Rennert","screen_name":"PDRennert","location":"Holliston, MA","url":"http:\/\/www.sugarconebiotech.com","description":"Nurturing new biotech companies at http:\/\/www.sugarconebiotech.com and blogging on drug development, science, the natural world","protected":false,"followers_count":652,"friends_count":709,"listed_count":21,"created_at":"Mon Dec 10 13:57:28 +0000 2012","favourites_count":34,"utc_offset":null,"time_zone":null,"geo_enabled":true,"verified":false,"statuses_count":2063,"lang":"en","contributors_enabled":false,"is_translator":false,"is_translation_enabled":false,"profile_background_color":"C0DEED","profile_background_image_url":"http:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_image_url_https":"https:\/\/abs.twimg.com\/images\/themes\/theme1\/bg.png","profile_background_tile":false,"profile_image_url":"http:\/\/pbs.twimg.com\/profile_images\/2957136517\/1be33cdb3df6ddb405064a7b669446fc_normal.jpeg","profile_image_url_https":"https:\/\/pbs.twimg.com\/profile_images\/2957136517\/1be33cdb3df6ddb405064a7b669446fc_normal.jpeg","profile_link_color":"0084B4","profile_sidebar_border_color":"C0DEED","profile_sidebar_fill_color":"DDEEF6","profile_text_color":"333333","profile_use_background_image":true,"default_profile":true,"default_profile_image":false,"following":null,"follow_request_sent":null,"notifications":null},"geo":null,"coordinates":null,"place":null,"contributors":null,"retweet_count":8,"favorite_count":5,"entities":{"hashtags":[],"symbols":[{"text":"CELG","indices":[62,67]}],"urls":[{"url":"http:\/\/t.co\/NqoLt9VDGT","expanded_url":"http:\/\/bit.ly\/1iqtAEj","display_url":"bit.ly\/1iqtAEj","indices":[94,116]}],"user_mentions":[]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"lang":"en"},"retweet_count":0,"favorite_count":0,"entities":{"hashtags":[],"symbols":[{"text":"CELG","indices":[77,82]}],"urls":[{"url":"http:\/\/t.co\/NqoLt9VDGT","expanded_url":"http:\/\/bit.ly\/1iqtAEj","display_url":"bit.ly\/1iqtAEj","indices":[109,131]}],"user_mentions":[{"screen_name":"PDRennert","name":"Paul D. Rennert","id":1001726569,"id_str":"1001726569","indices":[3,13]}]},"favorited":false,"retweeted":false,"possibly_sensitive":false,"filter_level":"medium","lang":"en"}
